Short-Term Efficacy and Safety of Extended-Release Fluvastatin in a Large Cohort of Elderly Patients
Of the 1643 eligible patients, 1229 were randomized and received the study treatment (fluvastatin XL 80 mg, n=607; placebo, n=622). The number of patients who discontinued the study was similar in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback